State Farm to Divest Entire 19.7% Stake in ADT, Valued at $849 Million
ADT is trading near its 52-week low of $6.24 (8.3% above the low).
Summary
State Farm Fire & Casualty Company is divesting its entire 19.7% stake in ADT, valued at $849 million, marking another major institutional exit following Apollo Funds' recent full divestment.
Key Events · Ownership and Investor Activity · ADT
-
Major Shareholder Divestment
State Farm Fire & Casualty Company is added as a selling stockholder, intending to sell its entire beneficial ownership of 133,333,333 shares of common stock, representing 19.7% of outstanding common stock.
-
Significant Transaction Value
The shares offered by State Farm are valued at approximately $849.3 million, based on an estimated offering price of $6.37 per share.
-
No Proceeds to Company
ADT Inc. will not receive any proceeds from the sale of shares by State Farm, as this is a secondary offering by an existing shareholder.
-
Follows Apollo's Full Exit
This divestment by State Farm follows the full exit of Apollo Funds, which sold their entire 102 million share stake in ADT through a secondary offering in May 2026.
Analysis · ADT · Trade & Services
This filing announces State Farm's intent to sell its entire 133.3 million share stake in ADT, representing 19.7% of the common stock and valued at approximately $849 million. This is a highly significant divestment by a major institutional investor, following closely on the heels of Apollo Funds' full exit from ADT in May 2026. The company will not receive any proceeds from this sale. The simultaneous existence of ADT's $1.5 billion share repurchase program creates a conflicting signal, as the company is buying back shares while major institutional holders are liquidating their entire positions. This large-scale selling by significant investors could create substantial market overhang and pressure on the stock price.
At the time of this filing, ADT was trading at $6.76 on NYSE in the Trade & Services sector, with a market capitalization of approximately $5B. The 52-week trading range was $6.24 to $8.94. This filing was assessed with negative market sentiment and an importance score of 8 out of 10.